News & Events

News

Here you will find the most recent news/events from our law firm as well as analyses and articles on the latest legal issues.

Year
Title
Healthcare and Life Sciences
Cannabis legalisation in Germany: What will change in the medical sector?
Healthcare and Life Sciences
Hot
Topic
The Digital Act: a boost for digitalisation in German healthcare
Firm News
Gleiss Lutz appoints four new partners and four new counsel
Healthcare and Life Sciences
Update on Cannabis Legalisation: Bill Finalised
Event
16.06.2023 16/06 12:30 PM Berlin Berlin
Healthcare Forum (German-language event)
Mandate
Gleiss Lutz advises Pitango on investment in digital health startup Patient21
Healthcare and Life Sciences Public Law
Bundestag debates government bill on medicines shortage
Healthcare and Life Sciences
Cannabis legalisation “light”
Mandate
Gleiss Lutz advises Daicel on the sale of Lomapharm
Healthcare and Life Sciences
German government adopts key proposals paper on cannabis legalisation
Mandate
Gleiss Lutz assists Federal Ministry of Health in defending ordinance on vaccinations for the 2022/2023 flu season
Healthcare and Life Sciences
Dynamic German Cannabis market: Rising medical use today | Recreational use tomorrow
Digital Economy Digital Future Healthcare and Life Sciences
Healthcare in the metaverse: The legal framework for medical treatment and the use of medical devices in the Medical Extended Reality
Mandate
Gleiss Lutz advises the shareholders of PlasmidFactory on investment by ArchiMed
Mandate
Gleiss Lutz advises Curaleaf on the acquisition of a majority stake and a strategic partnership with Four 20 Pharma

Mandates & Firm News

Click here for Information on our mandates and firm news

More

Know-How

We comment on current legal developments and issues for you
More

Events

Here you can get an overview of all Gleiss Lutz events at a glance More
Keep in Touch

Keep in Touch
Gleiss Lutz keeps you informed

We would be pleased to add you to our mailing list so that we can keep you informed about current legal developments and events.

Subscribe now